Other Species / Isoforms
  CD2AP (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K55-ac
MFPDNFVkEIkRETE
0 1
CD2AP (human) MFPDNFVkEIkRETE K55-ac
CD2AP (mouse) MFPDNFVKEIKRETE K55
CD2AP (rat) MFPDNFVKEIKRETE K55
K58-sm
DNFVkEIkRETEFKD
0 1
CD2AP (human) DNFVkEIkRETEFKD K58-sm
CD2AP (mouse) DNFVKEIKRETEPKD K58
CD2AP (rat) DNFVKEIKRETEPKD K58
S67-p
ETEFKDDsLPIkRER
0 3
CD2AP (human) ETEFKDDsLPIkRER S67-p
CD2AP (mouse) ETEPKDDNLPIkRER N67
CD2AP (rat) ETEPKDDNLPIKRER N67
K71-ub
KDDsLPIkRERHGNV
0 3
CD2AP (human) KDDsLPIkRERHGNV K71-ub
CD2AP (mouse) KDDNLPIkRERQGNV K71-ub
CD2AP (rat) KDDNLPIKRERPGNV K71
S80-p
ERHGNVAsLVQRIst
Upstream
0 14
Treatment
  • ischemia
CD2AP (human) ERHGNVAsLVQRIst S80-p
CD2AP (mouse) ERQGNVASLVQRIst S80
CD2AP (rat) ERPGNVASLVQRIST S80
S86-p
AsLVQRIstyGLPAG
0 8
CD2AP (human) AsLVQRIstyGLPAG S86-p
CD2AP (mouse) ASLVQRIstyGLPAG S86-p
CD2AP (rat) ASLVQRISTYGLPAG S86
T87-p
sLVQRIstyGLPAGG
0 5
CD2AP (human) sLVQRIstyGLPAGG T87-p
CD2AP (mouse) SLVQRIstyGLPAGG T87-p
CD2AP (rat) SLVQRISTYGLPAGG T87
Y88-p
LVQRIstyGLPAGGI
Upstream
1 247
Treatment
  • ephrin_B1
  • Su11274
CD2AP (human) LVQRIstyGLPAGGI Y88-p
CD2AP (mouse) LVQRIstyGLPAGGI Y88-p
CD2AP (rat) LVQRISTYGLPAGGI Y88
K102-ub
IQPHPQTkNIKKKTK
0 2
CD2AP (human) IQPHPQTkNIKKKTK K102-ub
CD2AP (mouse) IQPHPQTkAIKKKTK K102-ub
CD2AP (rat) IQPHPQTKAMKKKTK K102
S180-p
THEAQDDsETVLAGP
0 1
CD2AP (human) THEAQDDsETVLAGP S180-p
CD2AP (mouse) THNAQEESEVPLTGP S180
CD2AP (rat) MHDAQEESEVSLTGP S180
S189-p
TVLAGPTsPIPSLGN
0 4
CD2AP (human) TVLAGPTsPIPSLGN S189-p
CD2AP (mouse) VPLTGPTsPLPsPGN S189-p
CD2AP (rat) VSLTGPTSPMPSPGN S189
S193
GPTsPIPSLGNVSET
0 4
CD2AP (human) GPTsPIPSLGNVSET S193
CD2AP (mouse) GPTsPLPsPGNGSEP S193-p
CD2AP (rat) GPTSPMPSPGNGSEP S193
K221-ub
IGFGDIFkEGsVkLR
0 2
CD2AP (human) IGFGDIFkEGsVkLR K221-ub
CD2AP (mouse) IGFGDIFkEGsVKLR K221-ub
CD2AP (rat) VGFGDIFKEGsVKLR K221
S224-p
GDIFkEGsVkLRtRt
Upstream
0 24
Treatment
  • anti-CD3
CD2AP (human) GDIFkEGsVkLRtRt S224-p
CD2AP (mouse) GDIFkEGsVKLRtRt S224-p
CD2AP (rat) GDIFKEGsVKLRTRT S224-p
K226-ub
IFkEGsVkLRtRtss
0 1
CD2AP (human) IFkEGsVkLRtRtss K226-ub
CD2AP (mouse) IFkEGsVKLRtRtss K226
CD2AP (rat) IFKEGsVKLRTRTSS K226
T229-p
EGsVkLRtRtsssEt
0 16
CD2AP (human) EGsVkLRtRtsssEt T229-p
CD2AP (mouse) EGsVKLRtRtsssET T229-p
CD2AP (rat) EGsVKLRTRTSSSET T229
T231-p
sVkLRtRtsssEtEE
Upstream
0 107
Treatment
  • gefitinib
  • imatinib
  • Su11274
CD2AP (human) sVkLRtRtsssEtEE T231-p
CD2AP (mouse) sVKLRtRtsssETEE T231-p
CD2AP (rat) sVKLRTRTSSSETEE T231
S232-p
VkLRtRtsssEtEEK
0 94
CD2AP (human) VkLRtRtsssEtEEK S232-p
CD2AP (mouse) VKLRtRtsssETEEK S232-p
CD2AP (rat) VKLRTRTSSSETEEK S232
S233-p
kLRtRtsssEtEEKK
Upstream
1 364
Treatment
  • gefitinib
  • imatinib
  • metastatic potential
  • Su11274
  • wortmannin
CD2AP (human) kLRtRtsssEtEEKK S233-p
CD2AP (mouse) KLRtRtsssETEEKK S233-p
CD2AP (rat) KLRTRTSSSETEEKK S233
S234-p
LRtRtsssEtEEKKP
0 40
CD2AP (human) LRtRtsssEtEEKKP S234-p
CD2AP (mouse) LRtRtsssETEEKKT S234-p
CD2AP (rat) LRTRTSSSETEEKKS S234
T236-p
tRtsssEtEEKKPEk
0 9
CD2AP (human) tRtsssEtEEKKPEk T236-p
CD2AP (mouse) tRtsssETEEKKTEK T236
CD2AP (rat) TRTSSSETEEKKSEK T236
K243-ub
tEEKKPEkPLILQsL
0 1
CD2AP (human) tEEKKPEkPLILQsL K243-ub
CD2AP (mouse) TEEKKTEKPLILQPL K243
CD2AP (rat) TEEKKSEKPLILQSL K243
S249-p
EkPLILQsLGPKtQs
0 1
CD2AP (human) EkPLILQsLGPKtQs S249-p
CD2AP (mouse) EKPLILQPLGSRtQN P249
CD2AP (rat) EKPLILQSLGSRTQN S249
T254-p
LQsLGPKtQsVEITK
0 3
CD2AP (human) LQsLGPKtQsVEITK T254-p
CD2AP (mouse) LQPLGSRtQNVEVTK T254-p
CD2AP (rat) LQSLGSRTQNVEVTK T254
S256-p
sLGPKtQsVEITKTD
Upstream
0 9
Treatment
  • ischemia
CD2AP (human) sLGPKtQsVEITKTD S256-p
CD2AP (mouse) PLGSRtQNVEVTKPD N256
CD2AP (rat) SLGSRTQNVEVTKPD N256
K333-ub
VQINELDkDFPKPKK
0 1
CD2AP (human) VQINELDkDFPKPKK K333-ub
CD2AP (mouse) VQISELDKDFPKPKK K333
CD2AP (rat) VQISELDKDFPKPKK K333
K359-ac
PELIAAEkkyFsLkP
0 4
CD2AP (human) PELIAAEkkyFsLkP K359-ac
CD2AP (mouse) PDLSAAEKKAFPLKA K359
CD2AP (rat) PDPLAGEKKTFPLKA K359
K359-ub
PELIAAEkkyFsLkP
0 1
CD2AP (human) PELIAAEkkyFsLkP K359-ub
CD2AP (mouse) PDLSAAEKKAFPLKA K359
CD2AP (rat) PDPLAGEKKTFPLKA K359
K360-ac
ELIAAEkkyFsLkPE
0 1
CD2AP (human) ELIAAEkkyFsLkPE K360-ac
CD2AP (mouse) DLSAAEKKAFPLKAE K360
CD2AP (rat) DPLAGEKKTFPLKAE K360
Y361-p
LIAAEkkyFsLkPEE
0 77
CD2AP (human) LIAAEkkyFsLkPEE Y361-p
CD2AP (mouse) LSAAEKKAFPLKAEE A361
CD2AP (rat) PLAGEKKTFPLKAED T361
S363-p
AAEkkyFsLkPEEkD
0 31
CD2AP (human) AAEkkyFsLkPEEkD S363-p
CD2AP (mouse) AAEKKAFPLKAEEKD P363
CD2AP (rat) AGEKKTFPLKAEDRD P363
K365-ub
EkkyFsLkPEEkDEK
0 1
CD2AP (human) EkkyFsLkPEEkDEK K365-ub
CD2AP (mouse) EKKAFPLKAEEKDEK K365
CD2AP (rat) EKKTFPLKAEDRDEK K365
K369-ub
FsLkPEEkDEKSTLE
0 1
CD2AP (human) FsLkPEEkDEKSTLE K369-ub
CD2AP (mouse) FPLKAEEKDEKSLLE K369
CD2AP (rat) FPLKAEDRDEKSLLE R369
S380-p
STLEQKPsKPAAPQV
0 3
CD2AP (human) STLEQKPsKPAAPQV S380-p
CD2AP (mouse) SLLEQKPsKPAAPQV S380-p
CD2AP (rat) SLLEQKPSKPAAPQV S380
T393-p
QVPPKKPtPPtkASN
0 3
CD2AP (human) QVPPKKPtPPtkASN T393-p
CD2AP (mouse) QVPPKKPTAPTKASN T393
CD2AP (rat) QVPPKKPTPPTKANN T393
T396-p
PKKPtPPtkASNLLR
0 1
CD2AP (human) PKKPtPPtkASNLLR T396-p
CD2AP (mouse) PKKPTAPTKASNLLR T396
CD2AP (rat) PKKPTPPTKANNLLR T396
K397-ub
KKPtPPtkASNLLRS
0 1
CD2AP (human) KKPtPPtkASNLLRS K397-ub
CD2AP (mouse) KKPTAPTKASNLLRs K397
CD2AP (rat) KKPTPPTKANNLLRS K397
K397-m1
KKPtPPtkASNLLRS
0 1
CD2AP (human) KKPtPPtkASNLLRS K397-m1
CD2AP (mouse) KKPTAPTKASNLLRs K397
CD2AP (rat) KKPTPPTKANNLLRS K397
S404
kASNLLRSsGTVyPK
0 23
CD2AP (human) kASNLLRSsGTVyPK S404
CD2AP (mouse) KASNLLRsPGAVYPK S404-p
CD2AP (rat) KANNLLRSPGTMYPK S404
S405-p
ASNLLRSsGTVyPKR
0 1
CD2AP (human) ASNLLRSsGTVyPKR S405-p
CD2AP (mouse) ASNLLRsPGAVYPKR P405
CD2AP (rat) ANNLLRSPGTMYPKR P405
Y409-p
LRSsGTVyPKRPEkP
0 4
CD2AP (human) LRSsGTVyPKRPEkP Y409-p
CD2AP (mouse) LRsPGAVYPKRPEKP Y409
CD2AP (rat) LRSPGTMYPKRPEKP Y409
K415-ub
VyPKRPEkPVPPPPP
0 1
CD2AP (human) VyPKRPEkPVPPPPP K415-ub
CD2AP (mouse) VYPKRPEKPVPPPPP K415
CD2AP (rat) MYPKRPEKPVPPPPP K415
K425-ac
PPPPPIAkINGEVSS
0 2
CD2AP (human) PPPPPIAkINGEVSS K425-ac
CD2AP (mouse) PPPPPAAKINGEVsI K425
CD2AP (rat) PPPPPTAKINGEVST K425
S431
AkINGEVSSISSkFE
0 1
CD2AP (human) AkINGEVSSISSkFE S431
CD2AP (mouse) AKINGEVsIISSKID S431-p
CD2AP (rat) AKINGEVSTISSKID S431
K436-ub
EVSSISSkFETEPVS
0 1
CD2AP (human) EVSSISSkFETEPVS K436-ub
CD2AP (mouse) EVsIISSKIDTEPVS K436
CD2AP (rat) EVSTISSKIDTEPLS K436
K444-ub
FETEPVSkLkLDSEQ
0 1
CD2AP (human) FETEPVSkLkLDSEQ K444-ub
CD2AP (mouse) IDTEPVSKPKLDPEQ K444
CD2AP (rat) IDTEPLSKPKLDPEQ K444
K446-ac
TEPVSkLkLDSEQLP
0 1
CD2AP (human) TEPVSkLkLDSEQLP K446-ac
CD2AP (mouse) TEPVSKPKLDPEQLP K446
CD2AP (rat) TEPLSKPKLDPEQLP K446
K446-ub
TEPVSkLkLDSEQLP
0 1
CD2AP (human) TEPVSkLkLDSEQLP K446-ub
CD2AP (mouse) TEPVSKPKLDPEQLP K446
CD2AP (rat) TEPLSKPKLDPEQLP K446
K457-ub
EQLPLRPksVDFDsL
0 2
CD2AP (human) EQLPLRPksVDFDsL K457-ub
CD2AP (mouse) EQLPVRPksVDLDAF K457-ub
CD2AP (rat) EQLPVRPKsVDLDAL K457
S458-p
QLPLRPksVDFDsLt
Upstream
0 65
Treatment
  • anti-CD3
  • EGF
  • HB-EGF
  • ischemia
  • LPA
  • nocodazole
  • SB202190
CD2AP (human) QLPLRPksVDFDsLt S458-p
CD2AP (mouse) QLPVRPksVDLDAFV S458-p
CD2AP (rat) QLPVRPKsVDLDALV S458-p
S463-p
PksVDFDsLtVRTSk
0 8
CD2AP (human) PksVDFDsLtVRTSk S463-p
CD2AP (mouse) PksVDLDAFVARNsK A463
CD2AP (rat) PKsVDLDALVARNsK A463
T465-p
sVDFDsLtVRTSkET
0 3
CD2AP (human) sVDFDsLtVRTSkET T465-p
CD2AP (mouse) sVDLDAFVARNsKET V465
CD2AP (rat) sVDLDALVARNsKET V465
S469
DsLtVRTSkETDVVN
0 2
CD2AP (human) DsLtVRTSkETDVVN S469
CD2AP (mouse) DAFVARNsKETDDVN S469-p
CD2AP (rat) DALVARNsKETDNVN S469-p
K470-ub
sLtVRTSkETDVVNF
0 1
CD2AP (human) sLtVRTSkETDVVNF K470-ub
CD2AP (mouse) AFVARNsKETDDVNF K470
CD2AP (rat) ALVARNsKETDNVNF K470
K495-ub
HLTANRPkMPGRRLP
0 1
CD2AP (human) HLTANRPkMPGRRLP K495-ub
CD2AP (mouse) HLTANRPKMPGRRLP K495
CD2AP (rat) HLTANRPKMPGRRLP K495
K495-m1
HLTANRPkMPGRRLP
0 4
CD2AP (human) HLTANRPkMPGRRLP K495-m1
CD2AP (mouse) HLTANRPKMPGRRLP K495
CD2AP (rat) HLTANRPKMPGRRLP K495
S510-p
GRFNGGHsPtHsPEK
Upstream
0 62
Treatment
  • EGF
  • nocodazole
CD2AP (human) GRFNGGHsPtHsPEK S510-p
CD2AP (mouse) GRFNGGHsPtQsPEK S510-p
CD2AP (rat) GRFNGGHsPTQsPEK S510-p
T512-p
FNGGHsPtHsPEKIL
0 9
CD2AP (human) FNGGHsPtHsPEKIL T512-p
CD2AP (mouse) FNGGHsPtQsPEKTL T512-p
CD2AP (rat) FNGGHsPTQsPEKTL T512
S514-p
GGHsPtHsPEKILKL
Upstream
0 39
Treatment
  • EGF
CD2AP (human) GGHsPtHsPEKILKL S514-p
CD2AP (mouse) GGHsPtQsPEKTLKL S514-p
CD2AP (rat) GGHsPTQsPEKTLKL S514-p
S527
KLPKEEDSANLKPSE
0 1
CD2AP (human) KLPKEEDSANLKPSE S527
CD2AP (mouse) KLPKEDDsGNLKPLE S527-p
CD2AP (rat) KLPKDDDSGNIKPSE S527
T539-p
PSELKKDtCysPkPs
0 4
CD2AP (human) PSELKKDtCysPkPs T539-p
CD2AP (mouse) PLEFKKDASySSKSS A539
CD2AP (rat) PSEFKKDAGYSSKPS A539
Y541-p
ELKKDtCysPkPsVy
0 144
CD2AP (human) ELKKDtCysPkPsVy Y541-p
CD2AP (mouse) EFKKDASySSKSSLs Y541-p
CD2AP (rat) EFKKDAGYSSKPSLS Y541
S542-p
LKKDtCysPkPsVyL
Upstream
0 39
Treatment
  • ischemia
CD2AP (human) LKKDtCysPkPsVyL S542-p
CD2AP (mouse) FKKDASySSKSSLst S542
CD2AP (rat) FKKDAGYSSKPSLSA S542
K544-ub
KDtCysPkPsVyLst
0 1
CD2AP (human) KDtCysPkPsVyLst K544-ub
CD2AP (mouse) KDASySSKSSLstPs K544
CD2AP (rat) KDAGYSSKPSLSAPS K544
S546-p
tCysPkPsVyLstPs
0 17
CD2AP (human) tCysPkPsVyLstPs S546-p
CD2AP (mouse) ASySSKSSLstPssA S546
CD2AP (rat) AGYSSKPSLSAPSSA S546
Y548-p
ysPkPsVyLstPssA
Upstream
0 327
Treatment
  • imatinib
CD2AP (human) ysPkPsVyLstPssA Y548-p
CD2AP (mouse) gap -
CD2AP (rat) gap -
S550-p
PkPsVyLstPssAsk
0 3
CD2AP (human) PkPsVyLstPssAsk S550-p
CD2AP (mouse) ySSKSSLstPssASK S548-p
CD2AP (rat) YSSKPSLSAPSSASK S548
T551-p
kPsVyLstPssAskA
0 24
CD2AP (human) kPsVyLstPssAskA T551-p
CD2AP (mouse) SSKSSLstPssASKV T549-p
CD2AP (rat) SSKPSLSAPSSASKV A549
S553-p
sVyLstPssAskANT
0 5
CD2AP (human) sVyLstPssAskANT S553-p
CD2AP (mouse) KSSLstPssASKVNT S551-p
CD2AP (rat) KPSLSAPSSASKVNT S551
S554-p
VyLstPssAskANTT
0 14
CD2AP (human) VyLstPssAskANTT S554-p
CD2AP (mouse) SSLstPssASKVNTA S552-p
CD2AP (rat) PSLSAPSSASKVNTA S552
S556-p
LstPssAskANTTAF
Upstream
0 3
Treatment
  • nocodazole
CD2AP (human) LstPssAskANTTAF S556-p
CD2AP (mouse) LstPssASKVNTAAF S554
CD2AP (rat) LSAPSSASKVNTAAF S554
K557-ub
stPssAskANTTAFL
0 1
CD2AP (human) stPssAskANTTAFL K557-ub
CD2AP (mouse) stPssASKVNTAAFL K555
CD2AP (rat) SAPSSASKVNTAAFL K555
T565-p
ANTTAFLtPLEIkAK
Upstream
0 19
Treatment
  • AZD1152
  • BI2536
  • ZM447439
CD2AP (human) ANTTAFLtPLEIkAK T565-p
CD2AP (mouse) VNTAAFLtPLELkAK T563-p
CD2AP (rat) VNTAAFLSPLELKAK S563
K570-ub
FLtPLEIkAKVETDD
0 2
CD2AP (human) FLtPLEIkAKVETDD K570-ub
CD2AP (mouse) FLtPLELkAKAEADD K568-ub
CD2AP (rat) FLSPLELKAKVEADD K568
S582-p
TDDVKKNsLDELRAQ
0 17
CD2AP (human) TDDVKKNsLDELRAQ S582-p
CD2AP (mouse) ADDGKRNsVDELRAQ S580-p
CD2AP (rat) ADDGKKSsLDELRAQ S580-p
K613-ub
KELEKLRkDLEEEKT
0 1
CD2AP (human) KELEKLRkDLEEEKT K613-ub
CD2AP (mouse) KELEKLRKELEEEKA K611
CD2AP (rat) KELEKLRRELEEEKA R611
K631-ub
NLEMEIEkLKKAVLS
0 2
CD2AP (human) NLEMEIEkLKKAVLS K631-ub
CD2AP (mouse) NLEVEIAkLKKAVLL K629-ub
CD2AP (rat) NLEVEIAKLKKAVLL K629